Episode
The Medicine Exists. So Why Can’t Patients Get It?
- Podcast
- Paul Talks Science
- Published
- Jun 29, 2026
- Duration seconds
- 2357
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/paul-talks-science-7078474/episodes/the-medicine-exists-so-why-can-t-patients-get-it/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/paul-talks-science-7078474/the-medicine-exists-so-why-can-t-patients-get-it.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
A medicine can exist and still not reach the patient who needs it. In this episode, Paul Adepoju speaks with Herb Riband, Executive Director of Access Accelerated, about why access to medicines often breaks down between the laboratory, the procurement system and the patient. They discuss the financing gap for non-communicable diseases, the limits of focusing only on lower prices, and why African countries are increasingly looking at market shaping, pooled procurement and stronger local systems to make medicine supply more reliable. This conversation builds on Paul’s Re:solve Global Health story, “Can market shaping improve medicine access across Africa?” Read the story here